More specifically, investigating the dynamic regulation of SUMOylation and its impact on AD-related proteins, such as Tau, may provide insights into the mechanisms underlying AD pathophysiology and potential therapeutic targets for the disease. Here, MAPT is linked to Alzheimer disease.